{"filing":{"accession_number":"0001178913-26-003200","cik":"0001574565","ticker":"EVGN","company_name":"Evogene Ltd.","form":"6-K","filing_date":"2026-06-16","report_date":null,"primary_document":"zk2635546.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1574565/000117891326003200/zk2635546.htm"},"events":[{"id":12319,"run_id":10886,"accession_number":"0001178913-26-003200","anchor_item_number":"EX-99.1","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"summary":"This exhibit is a corporate presentation detailing Evogene's AI-driven drug and agrochemical discovery platform (ChemPass AI) and its pipeline collaborations. It discloses material operational and strategic developments including: (1) expanded collaboration with Google Cloud (initiated Feb. 2026) to integrate advanced AI agents into the discovery platform; (2) multiple pharma collaborations for oncology, metabolic disease, and immunology programs; (3) agrochemical pipeline progress including wheat blotch fungicide candidate (APTF-1) showing 18-month development timeline and strong in vivo efficacy. While the presentation emphasizes technology capabilities and market opportunity rather than discrete transactional events, the disclosed collaborations, pipeline advancement, and strategic partnerships constitute material operational developments affecting the company's business prospects and competitive positioning.","company_name":"Evogene Ltd.","ticker":"EVGN","filing_date":"2026-06-16","form":"6-K","submitted_at":null,"items":[{"id":9139,"accession_number":"0001178913-26-003200","item_number":"EX-99.1","item_title":"exhibit_99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This exhibit is a corporate presentation detailing Evogene's AI-driven drug and agrochemical discovery platform (ChemPass AI) and its pipeline collaborations. It discloses material operational and strategic developments including: (1) expanded collaboration with Google Cloud (initiated Feb. 2026) to integrate advanced AI agents into the discovery platform; (2) multiple pharma collaborations for oncology, metabolic disease, and immunology programs; (3) agrochemical pipeline progress including wheat blotch fungicide candidate (APTF-1) showing 18-month development timeline and strong in vivo efficacy. While the presentation emphasizes technology capabilities and market opportunity rather than discrete transactional events, the disclosed collaborations, pipeline advancement, and strategic partnerships constitute material operational developments affecting the company's business prospects and competitive positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:37:14.449542+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":9139,"accession_number":"0001178913-26-003200","item_number":"EX-99.1","item_title":"exhibit_99-1.htm","event_type":"operational_other","event_domain":"operational","is_material":true,"confidence":0.75,"reasoning":"This exhibit is a corporate presentation detailing Evogene's AI-driven drug and agrochemical discovery platform (ChemPass AI) and its pipeline collaborations. It discloses material operational and strategic developments including: (1) expanded collaboration with Google Cloud (initiated Feb. 2026) to integrate advanced AI agents into the discovery platform; (2) multiple pharma collaborations for oncology, metabolic disease, and immunology programs; (3) agrochemical pipeline progress including wheat blotch fungicide candidate (APTF-1) showing 18-month development timeline and strong in vivo efficacy. While the presentation emphasizes technology capabilities and market opportunity rather than discrete transactional events, the disclosed collaborations, pipeline advancement, and strategic partnerships constitute material operational developments affecting the company's business prospects and competitive positioning.","classifier_version":"claude-haiku-4-5-20251001+prompt-6be895f9","taxonomy_version":"v1.3","classified_at":"2026-06-22T02:37:14.449542+00:00","company_name":"Evogene Ltd.","ticker":"EVGN","filing_date":"2026-06-16"}]}